Kangmei Pharma | 600518 - Assets

Stock Price
1.62
Daily Change
-0.03 -1.82%
Monthly
-7.95%
Yearly
-17.77%
Q2 Forecast
1.59

Kangmei Pharma reported CNY13.68B in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Akebia Therapeutics USD 362.52M 14.04M Mar/2026
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
Avita Medical AUD 56.39M 1.74M Dec/2025
Cspc Pharmaceutical CNY 46.7B 695.56M Dec/2025
Dianthus Therapeutics USD 1.25B 715.96M Mar/2026
Genomma Lab Internacional MXN 24.8B 965.89M Mar/2026
Hypermarcas BRL 25.16B 4.34M Dec/2025
Ionis Pharmaceuticals USD 3.45B 74M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
Jiangsu Hengrui CNY 71.29B 1.43B Mar/2026
Kangmei Pharma CNY 13.68B 38.19M Sep/2025
Moderna USD 11.49B 850M Mar/2026
Organon & Co USD 13B 129M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Sh Fosun Pharma CNY 122.97B 2.91B Mar/2026
Tectonic Therapeutic USD 246.58M 14.46M Mar/2026
Viatris USD 36.83B 358.5M Mar/2026
Wuxi Apptec CNY 107.41B 4.29B Mar/2026
Xeris Pharmaceuticals USD 392.01M 8.49M Mar/2026
Zz Pientze Pharmaceu CNY 18.38B 905.93M Mar/2026